Preview Mode Links will not work in preview mode
Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape.  Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes  Value-based healthcare  Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials  Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Jun 21, 2021

Pierre Pellier is CEO of CTMA and is driven to provide better access to innovative and potentially life-saving therapies to more patients. The key is to shorten the duration of clinical trials by more quickly and efficiently identifying and recruiting potentially eligible participants.

Using the CT-Scout platform on a mobile device, doctors are prompted to ask, during a consultation, a few selected questions to determine whether a particular patient might be eligible for any of the numerous studies running at their site. Removing the need to remember major inclusion and exclusion criteria encourages doctors and investigators to broaden the search and increase recruitment.

@CScoutTm #CTMA #clinicaltrials #patientrecruitment

CTMA.fr

Listen to the podcast here

CTMA